Yolia Health
Yolia Health developed The True Vision Treatment or TVT, the 'Invisalign' for the eyes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
$3.0m | Series A | ||
| Total Funding | 000k | ||
Related Content
Yolia Health is a biomedical device company focused on providing non-invasive treatments to restore and enhance vision, particularly for individuals suffering from presbyopia. Presbyopia is a common age-related condition that affects over 135 million people in the United States and 2 billion people worldwide. Yolia Health offers a unique solution through customized eye drops that can significantly improve vision within just seven days. The company serves eye care providers and their patients, operating primarily in the healthcare and biomedical sectors. Yolia Health's business model revolves around the development and distribution of these specialized eye drops, generating revenue through sales to eye care professionals and clinics. The company is headquartered in San Diego, California, with additional offices in Mexico City, Mexico.
Keywords: presbyopia, vision restoration, non-invasive treatment, customized eye drops, biomedical device, eye care, healthcare, vision enhancement, age-related vision loss, San Diego.